Get a demo
Products
Solutions
Company
Resources
Careers
Get a demo
Products
Solutions
Company
Resources
Careers
Get a demo
Back to news
September 26, 2025
20% Faster Completion of High-Value Actions with Personalized HCP Engagement
By
Location
How one oncology brand uses Ostro Sites for HCPs to drive high‑value HCP actions
PanAgora Pharma CX AI & Tech Summit
Previous post
Next post
Reuters Pharma Customer Engagement USA
Previous post
Next post
Marcus Evans PharmaMarketing Summit
Previous post
Next post
Fierce Pharma Week 2026
Previous post
Next post
Fierce Webinar: Beyond the Digital Dead End: AI-Powered Brand Engagement
Previous post
Next post
Commercial Evidence with Veeva Ostro and Vault CRM
Previous post
Next post
Why Commercial Evidence is the Next Breakthrough in Pharma Intelligence
Previous post
Next post
How Brand Leaders Transform Websites from Brochures into Conversations with Veeva Ostro
Previous post
Next post
Powering Commercial Evidence to Uncover Treatment Barriers with More Precise Insights
Previous post
Next post
The Digital Dead End: Why Biopharma's Brand.com Playbook is Broken
Previous post
Next post
Ending the Pharma Relay Race with a Non-Opioid Breakthrough
Previous post
Next post
Veeva Ostro Conversational AI
Previous post
Next post
Commercial Evidence from Conversational AI for Patients and HCPs
Previous post
Next post
Unifying HCP and Patient Conversations Across All Channels
Previous post
Next post
America Is Running Out of Primary Care Doctors. AI Is Filling the Gap.
Previous post
Next post
The Future of AI for HCP + Patient Engagement
Previous post
Next post
The Opioid Crisis Was an Innovation Failure. Vertex Just Showed a Way to Fix It.
Previous post
Next post
Pharma marketing and the modern attention economy
Previous post
Next post
POV: Navigating the Rise of the AI-Informed Patient
Previous post
Next post
Veeva boosts its AI capabilities with Ostro acquisition
Previous post
Next post
Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
Previous post
Next post
Veeva Acquires Ostro the Leading Brand Engagement Platform for Life Sciences
Previous post
Next post
Why Biotech Startups Are Finally Ready to Beat Big Pharma at Their Own Game
Previous post
Next post
Trump’s ‘Great Healthcare Plan’ Aims to Cut Costs, but Details Are Sparse, Execs Say
Previous post
Next post
ChatGPT for Healthcare, Claude AI pose governance challenges
Previous post
Next post
This Pharma Exec Killed Their Deal on a Friday Morning — 18 Months Later, They Turned Her Into Their Biggest Advocate
Previous post
Next post
Transform Every Touchpoint: AI-powered Orchestration That Drives Measurable Engagement
Previous post
Next post
Boosting Patient Engagement and Brand Sentiment with Ostro
Previous post
Next post
10x Better Patient Engagement Through Personalized, Guided Treatment Journeys
Previous post
Next post
What’s on your 2026 health AI bingo card?
Previous post
Next post
6 Takeaways from Setting a Guinness World Records
Previous post
Next post
Ostro Wins MM+M's Best Places to Work 2025
Previous post
Next post
Ostro Named to Inc.’s 2025 Best in Business List for Best AI Implementation
Previous post
Next post
Ostro Breaks a World Record in Its Bid to Better Health AI Literacy
Previous post
Next post
Ostro, Havas Health Network receive Guinness record for online AI health literacy lesson
Previous post
Next post
Ostro and Havas Health Network Break Guinness World Record
Previous post
Next post
Spotlight On: Industry experts say TrumpRx may flip script on drug access, with Pfizer leading the way — if outcomes trump optics
Previous post
Next post
A former employee alleged Verily violated HIPAA – what healthcare marketers should know about the claims.
Previous post
Next post
Request Your Free eBook Now: AI's Impact on Medical Marketing
Previous post
Next post
If you build it, tariffs won’t come: Pharma’s billion-dollar ultimatum
Previous post
Next post
Ostro Debuts a New Digital Experience for Life Sciences Enabling Smarter, More Seamless AI-Powered Provider & Patient Engagement
Previous post
Next post
The End of One-Way Streets: How AI Is Transforming Pharma Email and SMS
Previous post
Next post
FDA's Undisclosed DTC Ad Letters Target Specific Drug Ads, Websites, Patient Brochures
Previous post
Next post
20% Faster Completion of High-Value Actions with Personalized HCP Engagement
Previous post
Next post
How AI is powering a new email tool to drive HCP engagement
Previous post
Next post
Ostro’s Airmark Revolutionizes Pharma Email Marketing with AI
Previous post
Next post
Ostro Debuts Airmark to Turn Static Pharma Emails into Real-Time, Compliant AI Conversations
Previous post
Next post
Sharing personal health data for monetary gain? Healthline’s California Conundrum
Previous post
Next post
Ostro Launches AI Tool For Clinicians To Engage With Pharma Companies
Previous post
Next post
Ostro Launches Airmark to Transform Static Pharma Marketing Emails into Compliant, Conversational AI
Previous post
Next post
AI anxiety has sent markets into a tizzy, but experts say the jitters will only ‘punish those chasing the froth’
Previous post
Next post
Pharma looks to appease Trumpwith DTC sales, but sidesteps MFNpricing
Previous post
Next post
The Flo Health – Meta data privacy case: What medical marketers can learn
Previous post
Next post
Navigating pharma's AI frontier: crafting customer journey orchestration for impact
Previous post
Next post
What do digital health leaders think of Trump’s new AI Action Plan?
Previous post
Next post
Industry looking to adapt under shadow of US Rx tariffs
Previous post
Next post
2025 Fierce Pharma Marketing Awards Finalists
Previous post
Next post
AI in Pharma: Why regulatory rigor is a catalyst, not a constraint
Previous post
Next post
Big Pharma borrows a page from pro athletes' marketing playbook
Previous post
Next post
A bright spot for biotech in Trump’s megabill
Previous post
Next post
Beyond food: GLP-1 drugs disrupt everything from casino apps, to retail, and airlines
Previous post
Next post
Four keys to successfully launching AI in life sciences
Previous post
Next post
Are there any healthcare wins hidden inside the One Big Beautiful Bill Act? Yes, a few…
Previous post
Next post
Trump’s executive order to lower Rx drug prices
Previous post
Next post
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Previous post
Next post
FDA's Elsa AI is here, and the industry has questions
Previous post
Next post
Why FDA's Elsa AI tool was inevitable (and just the beginning)
Previous post
Next post
FDA's new 'Elsa' AI set to expedite clinical protocol reviews
Previous post
Next post
White Paper: Transforming Life Sciences with Conversational AI
Previous post
Next post
Havas deepens AI leadership through strategic partnership with Ostro
Previous post
Next post
Ostro Files Provisional Patent for Machine Learning-Based Search Optimization Technology
Previous post
Next post
How pharma-backed websites are easing doctors’ search woes through AI
Previous post
Next post
Inside Takeda’s Plasma-Derived Therapy Ecosystem
Previous post
Next post
Ostro Partners with Desmoid Tumor Research Foundation
Previous post
Next post
Why Fine Tuning is Not Fine for Pharma Marketing
Previous post
Next post
Navigating the New ABPI Code: What Pharma Marketers Need to Know
Previous post
Next post
How Gilead Is Driving Global Health Equity And Innovation
Previous post
Next post
Ostro named Top 100 Healthcare Technology Companies of 2024
Previous post
Next post
Time on Website, or Wasting Time – What Pharma Brands Should Keep in Mind When Measuring Digital Engagement
Previous post
Next post
Ostro Helps Make Medicine Make Sense: Q/A with Ostro Co-Founder & President Ahmed Elsayyad
Previous post
Next post
‘More Siloed Than Ever’: Pharma’s Deep Digital Disconnect
Previous post
Next post
Bringing Best-in-Class Consumer Experience to Life Sciences
Previous post
Next post
A Consumerized Diagnostic: Looking Back And Ahead On A Decade Of Cologuard
Previous post
Next post
Staying Ahead of Medical Misinformation
Previous post
Next post
White Paper: How the Healthcare System Fails its Providers
Previous post
Next post
How This $4.3B Pharma Company Is Helping Underserved Patients in Neuro
Previous post
Next post
Three Ways AI is Revolutionizing Life Sciences Marketing
Previous post
Next post
White Paper: AI’s Rapid Evolution in Life Sciences Marketing and Sales
Previous post
Next post
Dermavant taps AI for ‘white-glove’ website service for Vtama psoriasis medicine
Previous post
Next post
How a Strategic Focus Defined Vertex's Mission
Previous post
Next post
Unlocking Brand Conversion: A Data-Driven Exploration
Previous post
Next post
Guide: Transforming Brand Interaction Through Empathy and Technology
Previous post
Next post
White Paper: Bridging the Information Gap
Previous post
Next post
Serendipity And Science: Forging Billion-Dollar Oncology Breakthroughs
Previous post
Next post
Pharma's Two Biggest Mistakes
Previous post
Next post
How this CEO Built a Top 50 Pharma Company Focusing on Culture Day 1
Previous post
Next post
A Decade of Innovation: How this CEO Transformed a Global Pharma Giant
Previous post
Next post
How This CEO Consumerized Cancer Diagnostics Into A $13B Enterprise
Previous post
Next post
40 Under 40: Dr. Chase Feiger, Ostro
Previous post
Next post
How this CEO Built A Top 50 Pharma Company Focusing On Culture Day 1
Previous post
Next post
Schedule a demo
.svg)